These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36943473)

  • 1. Novel oral medications for retinal disease: an update on clinical development.
    DeBoer CMT; Agrawal R; Rahimy E
    Curr Opin Ophthalmol; 2023 May; 34(3):203-210. PubMed ID: 36943473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical challenges for developing long acting intravitreal medicines.
    Awwad S; Henein C; Ibeanu N; Khaw PT; Brocchini S
    Eur J Pharm Biopharm; 2020 Aug; 153():130-149. PubMed ID: 32445965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story.
    Quiroz-Mercado H; Ustariz-González O; Martinez-Castellanos MA; Covarrubias P; Dominguez F; Sanchez-Huerta V
    Semin Ophthalmol; 2007; 22(2):109-25. PubMed ID: 17564934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII).
    Wang R; McClard CK; Laswell S; Mahmoudzadeh R; Salabati M; Ammar M; Vannavong J; Aziz AA; Ewald A; Calvanese AV; Lehman EB; Fried S; Windham V; Strutt A; Saroj N; Khanani AM; Eichenbaum DA; Regillo C; Wykoff CC
    BMJ Open Ophthalmol; 2022 Dec; 7(1):. PubMed ID: 36794741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
    Parikh R; Ross JS; Sangaralingham LR; Adelman RA; Shah ND; Barkmeier AJ
    Ophthalmology; 2017 Mar; 124(3):352-358. PubMed ID: 27890437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Tsao YC; Chen TY; Wang LA; Lee CC; Lee WA; Hsu SM; Lai CC; Shao SC; Hung JH; Lai EC
    BioDrugs; 2023 Nov; 37(6):843-854. PubMed ID: 37676536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal Bevacizumab in Diabetic Retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 Knobloch Lecture.
    Arevalo JF; Liu TYA;
    Asia Pac J Ophthalmol (Phila); 2018; 7(1):36-39. PubMed ID: 29280367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
    Campbell M; Doyle SL
    Biochem Pharmacol; 2019 Jun; 164():321-325. PubMed ID: 31039332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of intravitreal therapy for retinal and macular disorders.
    Panos GD
    J Int Med Res; 2020 Jan; 48(1):300060518771411. PubMed ID: 29726284
    [No Abstract]   [Full Text] [Related]  

  • 12. Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review.
    Liberski S; Wichrowska M; Kocięcki J
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center.
    Carnevali A; Giannaccare G; Gatti V; Scuteri G; Randazzo G; Scorcia V
    Eur J Ophthalmol; 2021 Jan; 31(1):10-12. PubMed ID: 32967465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.
    Battaglia Parodi M; Romano F; Arrigo A; Sacchi R; Scanzi G; Ferri C; Bandello F
    Eur J Ophthalmol; 2020 Nov; 30(6):1461-1466. PubMed ID: 31617403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
    Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel drug delivery systems for retinal diseases. A review.
    Lee SS; Robinson MR
    Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an immersive, interactive medical education initiative on guideline-based retinal disease management knowledge/competence and effectual practice change.
    Singh RP; Welch L; Longo NL; Frese M
    BMC Ophthalmol; 2023 Jun; 23(1):285. PubMed ID: 37349689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal diseases.
    Stern HD; Hussain RM
    Expert Opin Investig Drugs; 2022 May; 31(5):443-449. PubMed ID: 35285359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Bevacizumab: Indications And Complications.
    Jan S; Nazim M; Karim S; Hussain Z
    J Ayub Med Coll Abbottabad; 2016; 28(2):364-368. PubMed ID: 28718542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Borkar DS; Obeid A; Su DC; Storey PP; Gao X; Regillo CD; Kaiser RS; Garg SJ; Hsu J;
    Am J Ophthalmol; 2018 Oct; 194():1-6. PubMed ID: 29981738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.